Prolavir LR Tablet

Prolavir LR Tablet is an antiretroviral medication from the protease inhibitors class, containing the active ingredients Lopinavir and Ritonavir. It is indicated for treatment of HIV-1 infection. HIV-1 is a retrovirus that progressively attacks and weakens a person's immune system, increasing vulnerability to opportunistic infections.

Pre-existing liver disease, including Hepatitis B, Hepatitis C, or other liver conditions, increases the risk of developing new or worsening hepatic illness during Prolavir LR Tablet treatment. Patients should inform their healthcare provider immediately of signs and symptoms of liver impairment, including loss of appetite, dark-coloured urine, jaundice (yellow discolouration of skin and sclera), and pale-coloured stools.

Patients with elevated triglyceride levels carry increased risk of developing pancreatitis, an inflammatory condition of the pancreatic gland located behind the stomach. Those with a history of pancreatitis face greater likelihood of recurrence during treatment with this medication.

During early stages of HIV-1 treatment, some patients may experience immune reconstitution inflammatory syndrome (IRIS), an inflammatory response directed at opportunistic infections. This condition can occur following initiation of Prolavir LR Tablet or other antiretroviral therapies. Patients should be aware of this possibility and monitored for signs of worsening infections or inflammatory symptoms. Healthcare providers should be informed if symptoms are concerning or persist beyond the expected timeframe.

Prolavir LR Tablet is contraindicated in patients with documented allergy to Lopinavir, Ritonavir, or any excipient. Patients must inform their healthcare provider of all currently taken medications, including herbal preparations and dietary supplements, prior to commencing treatment.

Treatment of HIV-1 infection

Prolavir LR Tablet work together to inhibit the protease enzyme, which is necessary for the replication of HIV. By blocking this enzyme, this drug prevents the virus from multiplying and spreading in the body. It mainly helps reduce the viral load and slow the progression of HIV infection.

It is an orally available prescription drug. Your doctor will decide the dose and duration of the drug based on the disease condition and other factors. Always take Prolavir LR Tablet as prescribed by your doctor. Take the tablet with or without food. Do not break, chew, crush, or break the tablet. Swallow the whole tablet with water.

Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Serious Osteonecrosis (stiffness and pain in joints, difficulty moving) Lactic acidosis (breathing difficulties along with weakness in limbs, stomach pain, and drowsiness) Symptoms of muscle weakness or infection Changes in body fat Inflammation of the pancreas (nausea, vomiting, along with abdominal pain) Liver problems (yellow skin and whites of eyes, dark-colored urine, pale-colored stools, loss of appetite) High blood sugar (Increased thirst or urination) Severe allergic reactions Common Diarrhea Increased lipid levels in the blood

To prevent the spread of HIV infection, avoid sharing needles or syringes, which can transmit HIV-1 infections easily. It's necessary for individuals who use injectable drugs to use sterile needles and syringes and never share them with others. Personal items like toothbrushes, razor blades, or anything with body fluids or blood on them should also be avoided. They should not be shared because HIV-1 can be present in blood and certain body fluids, and sharing these items could mainly transmit the virus. Since this drug is unsafe for breastfeeding because HIV infection can be passed to the baby in the breast milk, alternative feeding methods can be followed to nourish the infant's growth. If you forget to take Prolavir LR Tablet for the entire day, take your usual dose the next day. However, do not double-dose yourself.